KDR and neoplasm: More importantly, the HGF/c-Met signaling is one of the most frequently dysregulated pathways in hepatocellular carcinoma [43], targeting of this pathway directly suppressed tumor growth and metastasis by a dual blockade of VEGFR2 and c-Met activation [44].